期刊文献+

结缔组织病肺间质疾病临床及高分辨CT特点分析 被引量:5

The Analysis of Clinical and High Resolution CT Characteristics of Connective Tissue Disease-Related Interstitial Lung Diseases
下载PDF
导出
摘要 目的:通过对不同种类结缔组织病(CTD)肺间质疾病(ILD)的临床及高分辨CT(HTCT)影像表现进行总结分析,研究其临床及HTCT影像特点,判断病情及预后。方法:回顾性分析53例不同CTD-ILD的临床及高分辨CT(HRCT)表现,总结不同CTD-ILD的临床表现及影像表现特点:相关数据进行统计学处理,研究其可能的相关性。结果:53例CTD-ILD的临床表现,咳嗽/干咳占56.6%;胸闷/气短占43.4%;呼吸困难39.6%;胸痛37.7%;爆裂音81.1%;pSS-ILD干咳发生率明显高于其它组(P﹤0.05);SSc-ILD呼吸困难发生率明显高于其它组(P﹤0.05)。HRCT影像表现特点:磨玻璃影50.9%;网格影28.3%,蜂窝影26.4%,实变影17.0%,结节影9.4%。RA-ILD、pSS-ILD磨玻璃影发生率明显高于其它组(P﹤0.05),SSc-ILD的网格影、蜂窝影发生率明显高于其它组(P﹤0.05)。结论:不同CTD-ILD临床和影像表现具有特征性,部分临床表现与影像表现之间具有一定的相关性。 Objective: To study the clinical and imaging features of HTCT and determine the condition and prognosis of different types of connective tissue disease(CTD) interstitial lung disease(ILD). Method: Retrospective analysed 53 patients with CTD-ILD in different clinical and high-resolution CT(HRCT) performance,summarized the different clinical manifestation of CTD-ILD and imaging performance characteristics,the data were analyzed statistically to study the possible correlation. Result: 53 patients with CTD-ILD of clinical manifestations:cough / dry cough was 56.6%;chest tightness/shortness of breath was 43.4%;dyspnea was 39.6%;chest pain was 37.7%;crackles was 81.1%;pSS-ILD dry cough was significantly higher than the other groups(P〈0.05);SSc-ILD dyspnea were significantly higher than the other groups(P〈0.05).HRCT images show features: ground glass opacity was 50.9%;reticular change was 28.3%,honeycomb change was 26.4%,consolidation was 17.0%,nodules was 9.4%.RA-ILD 、pSS-ILD ground glass were significantly higher than other groups(P〈0.05),SSc-ILD grid shadow,honeycombing were significantly higher than the other groups(P〈0.05). Conclusion:Different CTD-ILD in clinical and imaging findings with characteristic,Part of the clinical manifestations and imaging performance have some correlation.
出处 《河北医学》 CAS 2011年第11期1465-1468,共4页 Hebei Medicine
关键词 结缔组织病 肺间质疾病 临床表现 高分辨CT Connective tissue disease Interstitial lung diseases Clinical manifestation HTCT
  • 相关文献

参考文献4

二级参考文献25

  • 1The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction. Thorax, 1999,54 Suppl 1 : S1-S14.
  • 2Strange C, Highland KB. Interstitial lung disease in the patient who has connective tissue disease. Clin Chest Med, 2004,25: 549 -559.
  • 3Bouros D, Wells AU, Nicholson AG, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med, 2002, 165 : 1581-1586.
  • 4Cannona L, Gonzalez-Alvaro I, Balsa A, et al. Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis, 2003,62:897-900.
  • 5Vassallo R, Thomas CF. Advances in the treatment of rheumatic interstitial lung disease. Curr Opin Rheumatol, 2004, 16: 186- 191.
  • 6Marie I, Hachulla E, Cherin P, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum, 2002, 47: 614-622.
  • 7Sato H, Lagan AL, Alexopoulou C, et al. The TNF-863A allele strongly associates with anticentromere antibody positivity in scleroderma. Arthritis Rheum, 2004,50:558-564.
  • 8Sugiura Y, Banno S, Matsumoto Y, et al. Transforming growth factor betal gene polymorphism in patients with systemic sclerosis. J Rheumatol, 2003,30 : 1520-1523.
  • 9Schnabel A, Reuter M, Biederer J, et al. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum, 2003, 32:273-284.
  • 10Tashkin DP, Elashoff R, Clements PJ, et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med, 2006, 354 : 2655 -2666.

共引文献49

同被引文献56

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部